Pnc Financial Services Group, Inc. Vbi Vaccines Inc Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.27 - $2.47 $3,685 - $7,167	-2,902 Reduced 18.84%	12,500 $20,000
Q4 2021 Feb 11, 2022	BUY	$2.21 - $3.22 $15,368 - $22,391	6,954 Added 82.32%	15,402 $36,000
Q3 2021 Nov 05, 2021	BUY	$2.8 - $3.72 $19,216 - $25,530	6,863 Added 433.0%	8,448 $26,000
Q2 2021 Aug 06, 2021	BUY	$2.61 - $4.17 $4,136 - $6,609	1,585 New	1,585 $5,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.